Ambry CancerNext (Common Cancer Panel)

Synonyms

• AMBRY CANCERNEXT (COMMON CANCER PANEL)
• Hereditary Cancer
• LAB14847

Cerner Name

Ambry CancerNext (Common Pan Cancer) Panel

Clinical Info

Guideline-based, pan-cancer test that covers the most common hereditary cancer types, including hereditary breast, ovarian, pancreatic, prostate, colorectal/polyps, endometrial, gastric, small bowel, urothelial, and renal cancers. 40 genes are included in the analysis: APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, FLCN, GREM1, HOXB13, MBD4, MET, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, RPS20, SMAD4, STK11, TP53, TSC1, TSC2, VHL

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Buccal

Specimen Types

Blood Swab

Specimen Volume

4mL

Container

Lavender Top Tube (EDTA whole blood) or Buccal Swab

Collection Instructions

Whole Blood

Transport Instructions

Room Temperature

Specimen Stability

72 Hours Room Temperature7 Days RefrigeratedBuccal Swab- 6 Days Room Temperature

Methodology

Next Generation Sequencing (NGS)

Days Performed

Monday-Saturday

Performing Laboratories

• Ambry Genetics Laboratory

CPT

81432 or 81435

PDM

255307

Results

Result Interpretation

Forms